APIM Therapeutics
-
2009
Company Description
APIM Therapeutics is based on an original discovery by Prof. Marit Otterlei and co-inventors at the Department of Cancer Research and
APIM Therapeutics is based on an original discovery by Prof. Marit Otterlei and co-inventors at the Department of Cancer Research and Molecular Medicine at NTNU (Trondheim, Norway). The company is currently developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen), a key DNA repair protein regulating cellular responses to DNA damage and stress.
-
Manufacturer:
Science and Engineering -
Formed:
2009 -
Company Website:
-
Company E-mail:
-
Company Address:
c/o NTNU Technology Transfer AS, Sem Sælandsvei 14, Kjemiblokk 1, 3etgTrondheimNorway -
CEO:
- Konstantinos Alevizopoulos
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits